News Archive - All Stories

Seafloor Survey Finds Thousands of Barrels at DDT Dumpsite off LA Coast

An expedition led by UC San Diego’s Scripps Institution of Oceanography mapped more than 36,000 acres of seafloor between Santa Catalina Island and the Los Angeles coast in a region previously found to contain high levels of the toxic chemical DDT in sediments and the ecosystem.

Republicans Became More Vaccine Hesitant as the Coronavirus Pandemic Unfolded

Individuals who self-identify as Republicans became more skeptical of a potential COVID-19 vaccine and other inoculations, such as the flu shot, over the course of the pandemic, reveals a new study by the University of California San Diego’s Rady School of Management.

How SARS-CoV-2 Hijacks Human Cells to Evade Immune System

UC San Diego School of Medicine researchers discovered one way in which SARS-CoV-2 hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

Building a Voice Assistant for Older Adults

Computer scientists at the University of California San Diego received an Amazon Research Award to develop a voice assistant to better communicate with older adults. Their initial goal is to create a system capable of understanding and answering the medical questions of adults over age 65.

Neural Implant Monitors Multiple Brain Areas at Once, Provides New Neuroscience Insights

How do different parts of the brain communicate with each other during learning and memory formation? A study by researchers at UC San Diego takes a first step at answering this fundamental neuroscience question, thanks to a neural implant that monitors multiple brain regions at the same time.

Genetic Changes in Head and Neck Cancer, Immunotherapy Resistance Identified

A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.